DataMeds AI Discloses Nasdaq Listing Deficiency Notice

DataMeds AI said it received a Nasdaq deficiency notice on April 13, 2026, for failing to meet the $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1). It says it has since converted payables to equity and completed other transactions, believes it now exceeds the threshold, and is awaiting Nasdaq’s determination.